| Nom |
riboside d’allopurinol |
| Synonymes |
Riboside d’allopurinol ; 4-hydroxy(3,4-d)pyrazolopyrimidine riboside ; 4-hydroxy-1beta-D-ribofuranosylpyrazolo(3,4-d)pyrimidine ; Allopurinol ribonucléoside ; Allopurinol-1-ribonucléoside ; 138437 du CNS ; 1,5-dihydro-1-bêta-D-ribofuranosyl-4H-pyrazolo(3,4-d)pyrimidine-4-one ; 4H-Pyrazolo(3,4-d)pyrimidine-4-one, 1,5-dihydro-1-bêta-D-ribofuranosyl- ; 1-(bêta-L-ribofuranosyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one ; 1-pentofuranosyl-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one ; 1-(bêta-D-ribofuranosyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one ; 1-[(2S,3S,4R,5R)-3,4,5,6-tétrahydroxytétrahydro-2H-pyrane-2-yl]-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one (nom non préféré) |
| Nom anglais |
allopurinol riboside;Allopurinol riboside; 4-Hydroxy(3,4-d)pyrazolopyrimidine riboside; 4-Hydroxy-1beta-D-ribofuranosylpyrazolo(3,4-d)pyrimidine; Allopurinol ribonucleoside; Allopurinol-1-ribonucleoside; NSC 138437; 1,5-Dihydro-1-beta-D-ribofuranosyl-4H-pyrazolo(3,4-d)pyrimidin-4-one; 4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-1-beta-D-ribofuranosyl-; 1-(beta-L-ribofuranosyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one; 1-pentofuranosyl-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one; 1-(beta-D-ribofuranosyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one; 1-[(2S,3S,4R,5R)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl]-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (non-preferred name) |
| Formule moléculaire |
C10H12N4O6 |
| Poids Moléculaire |
284.2255 |
| InChI |
InChI=1/C10H12N4O6/c15-4-5(16)9(20-10(19)6(4)17)14-7-3(1-13-14)8(18)12-2-11-7/h1-2,4-6,9-10,13,15-17,19H/t4-,5+,6-,9+,10?/m1/s1 |
| Numéro de registre CAS |
16220-07-8 |
| Structure moléculaire |
|
| Densité |
2.25g/cm3 |
| Point d'ébullition |
566°C at 760 mmHg |
| Indice de réfraction |
1.925 |
| Point d'éclair |
296.1°C |
| Pression de vapeur |
3.62E-15mmHg at 25°C |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
